3rd vaccine on phase 3 trial in US, Mexico

Clinical trials to determine the safety and efficacy of a coronavirus disease 2019 (Covid-19) vaccine candidate from American biotech company Novavax have begun in the United States and Mexico, the US National Institutes of Health (NIH) announced Monday.